AstraZeneca braced for hostile bid from Pfizer

Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its €76bn takeover offer was spurned.

AstraZeneca braced for hostile bid from Pfizer

Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its €76bn takeover offer was spurned.

The UK company said the offer “substantially” undervalued the business, forcing Pfizer to consider its next move.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited